SM

Sushant Mahajan

Active Director Director DIN 09151987
DIN 09151987 First appointment Apr 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Sushant Mahajan

Data last updated:

Sushant Mahajan is a Director at Shl Pharma Private Limited (since 2021). The company operates in Chemicals.

DIN 09151987
Primary Designation Director
Industry Chemicals
First Appointment 29 Apr 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shl Pharma Private Limited U24290HP2021PTC008535
Director29 Apr 20212021Active

Board colleagues of Sushant Mahajan

NameDINCompanyDesignation
Lekh Raj09151975Shl Pharma Private LimitedDirector
Nisha09151992Shl Pharma Private LimitedDirector
Sahib Singh09151801Shl Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Shl Pharma Private Limited
Premium access

Shareholding and investment profile for Sushant Mahajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sushant Mahajan

Sushant Mahajan currently holds 1 directorship: Shl Pharma Private Limited (Director, since 29 Apr 2021).

Sushant Mahajan was first appointed on 29 Apr 2021 as Director at Shl Pharma Private Limited.

The current boards of Sushant Mahajan's companies include Lekh Raj (Shl Pharma Private Limited), Nisha (Shl Pharma Private Limited), Sahib Singh (Shl Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available